More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

BACKGROUND: There are substantial global differences in the preference for mercaptopurine (MP) or its prodrug azathioprine (AZA) as first-choice thiopurine to treat inflammatory bowel diseases. Studies comparing both agents are scarce. Our aim was to compare AZA and MP in thiopurine-naive patients w...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Inflamm Bowel Dis
Main Authors: Broekman, Mark M. T. J., Coenen, Marieke J. H., van Marrewijk, Corine J., Wanten, Geert J. A., Wong, Dennis R., Verbeek, Andre L. M., Klungel, Olaf H., Hooymans, Piet M., Guchelaar, Henk-Jan, Scheffer, Hans, Derijks, Luc J. J., de Jong, Dirk J.
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2017
Assuntos:
Original Clinical Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5598908/
https://ncbi.nlm.nih.gov/pubmed/28644183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0000000000001163
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares